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Alcohol dependence is associated with alteration of glutamate transport and glutamate
neurotransmission. Glutamate transporter 1 (GLT-1) is a major transporter that regulates
the majority of extracellular glutamate concentration, which is also regulated by
cystine-glutamate exchanger (xCT). Importantly, we recently reported that amoxicillin
and Augmentin (amoxicillin/clavulanate) upreglulated GLT-1 expression in nucleus
accumbens (NAc) and prefrontal cortex (PFC) as well as reduced ethanol consumption
in male P rats. In this study, we examined the effects of amoxicillin and Augmentin on
GLT-1 isoforms (GLT-1a and GLT-1b), xCT, and glutamate/aspartate transporter (GLAST)
expression in NAc and PFC as well as ethanol intake in male P rats. We found that both
compounds significantly reduced ethanol intake, and increased GLT-1a, GLT-1b, and
xCT expression in NAc. However, only Augmentin increased GLT-1a, GLT-1b, and xCT
expression in PFC. There were no effects of these compounds on GLAST expression
in NAc and PFC. These findings demonstrated that Augmentin and amoxicillin have the
potential to upregulate GLT-1 isoforms and xCT expression, and consequently attenuate
ethanol dependence.
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INTRODUCTION
Glutamate neurotransmission has a critical role in alcohol dependence and other drugs of abuse,
which involving several mesocorticolimbic brain regions, including nucleus accumbens (NAc) and
prefrontal cortex (PFC) (Goldstein and Volkow, 2002; Obara et al., 2009; Das et al., 2015). PFC is a
brain region that was suggested to regulate cognitive and emotional processes and triggers drug
seeking (Goldstein and Volkow, 2002), and the NAc has long been implicated in goal-directed
drug seeking behavior (Childress et al., 1999). Glutamate appears to be the primary driver of
PFC neurons, and drug seeking requires the release of this glutamate from the PFC to the NAc
(Childress et al., 1999; Goldstein and Volkow, 2002; Shalev et al., 2002; Capriles et al., 2003;
McFarland et al., 2003). Therefore, we tested the effects of amoxicillin and Augmentin on certain
glutamate transporters in NAc and PFC. Glutamate transporter 1 (GLT-1, its human homolog
is excitatory amino acid transporter 2, EAAT2) is a key transporter that regulates the majority
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of extracellular glutamate concentration in the brain (Rothstein
et al., 1996; Tanaka et al., 1997; Danbolt, 2001). Importantly,
studies from our laboratory revealed that chronic ethanol
intake reduced GLT-1 expression and increased the extracellular
glutamate concentration in NAc (Das et al., 2015). This study
also demonstrated that treatment with ceftriaxone, β-lactam
antibiotic known to upregulate GLT-1, reversed the effects
of ethanol exposure. Furthermore, we reported that male P
rats administered Augmentin or amoxicillin showed reduction
in ethanol consumption, which was associated in part with
upregulation of GLT-1 expression in PFC and NAc (Goodwani
et al., 2015).
In the present study, we focused our investigation on GLT-
1 isoforms (GLT-1a and GLT-1b) and other glial glutamate
transporters such as cystine-glutamate exchanger (xCT) and
glutamate/aspartate transporter (GLAST, its human homolog
is EAAT1). The focus on investigating GLT-1 isoforms was
based on the fact that these proteins are differentially expressed
according to a disease model. For instance, patients with
amyotrophic lateral sclerosis were found to have upregulated
GLT-1b expression and downregulated GLT-1a expression in
motor cortex (Maragakis et al., 2004). In addition, GLT-
1a is expressed in neurons and astrocytes, however, GLT-
1b is expressed mainly in astrocytes (Berger et al., 2005;
Holmseth et al., 2009). The difference in their ability to regulate
extracellular glutamate concentration has not been confirmed
yet. Thus, the present study investigated for the first time
the effects of chronic ethanol exposure on the expression of
GLT-1 isoforms. We also investigated xCT, which is another
glial glutamate transporter that was also shown to regulate
extracellular glutamate concentration (Baker et al., 2002; Moran
et al., 2005). xCT exchanges internal glutamate for external
cystine with the electrochemical gradient (Volterra et al., 1996;
Danbolt, 2001). In addition, xCT is co-expressed with GLT-1
in astrocytes to regulate extracellular glutamate concentration.
Decrease of xCT expression can affect extracellular glutamate
concentration, which can lead to loss of glutamatergic tone on
presynaptic mGluR2/3, thereby causing an increase in synaptic
glutamate release (Moran et al., 2005). Finally, we investigated the
effects of ethanol exposure as well as Augmentin and amoxicillin
treatments on GLAST expression in PFC and NAc.
MATERIALS AND METHODS
Animals
Male P rats were obtained from Indiana University, School of
Medicine (Indianapolis, IN, USA) at the age of 21–30 days,
and housed in the Department of Laboratory Animal Resources,
University of Toledo, Health Science Campus. At the age of 90
days, rats were individually housed in a plastic corn-cob bedding
tubs and had a free access to food and water ad lib. The room
temperature was maintained at 21◦C and 50% humidity with a
12-h light-dark cycle to resemble the natural habitat throughout
the experiment procedures. All animal procedures were in
compliance and approved by the Institutional Animal Care
and Use committee of The University of Toledo in accordance
with the guidelines of the Institutional Animal Care and Use
Committee of the National Institutes of Health and the Guide for
the Care and Use of Laboratory Animals.
Behavioral Drinking Paradigms
Male P rats were exposed to free choice of two ethanol
concentrations, 15 and 30%, (except for the ethanol naïve (water)
group), water and food for a period of 5 weeks. After the third
week of drinking paradigm, ethanol and water intakes were
measured three times a week for 2 weeks and used as a baseline.
The ethanol and water intake measurements were expressed as
g/kg of body weight/day. Animals with a baseline ethanol intake
of less than 4 g/kg/day were not included in the study as it was
adopted in previous studies (Sari et al., 2011, 2013; Sari and
Sreemantula, 2012). At the age of 3 months, rats were randomly
divided into four different groups: (a) Ethanol naïve group, which
had a free access to water and food only for 5 weeks, and received
five consecutive daily i.p. injections of saline vehicle solution
on Week 6 (n = 6); (b) Ethanol-vehicle (saline) group, which
received five consecutive daily i.p. injections of saline vehicle
solution on Week 6 (n = 6); (c) Ethanol-amoxicillin group,
which received five consecutive daily 100mg/kg, i.p. injections
of amoxicillin on Week 6 (n = 6); and (d) Ethanol-Augmentin
group received five consecutive daily 100mg/kg, i.p. injections of
Augmentin on Week 6 (n = 6).
Brain Tissue Harvesting
Rats were euthanized 24 h after the last i.p. injections of
saline or drugs using carbon dioxide and directly decapitated
with guillotine. Brains were then immediately placed on dry
ice and stored at −80◦C. Brain regions (PFC and NAc)
were dissected according to the Rat Brain Atlas (Paxinos and
Watson, 1997) using cryostat apparatus set at −20◦C. Extracted
brain regions were then stored at −80◦C for western blot
analysis.
Western Blot Protocol for Detection of
GLT-1 Isoforms, xCT, and GLAST
Brain regions were lysed using regular lysis buffer as described in
recent work (Sari et al., 2011). Protein transfer was performed on
a PVDF membrane using gel electrophoresis method (Bio-Rad,
Hercules, CA). Then, membranes were blocked with 3% milk
in TBST (50mM Tris HCl; 150mM NaCl, pH 7.4; 0.1% Tween
20) for 30min at room temperature. Moreover, membranes
were incubated overnight at 4◦C with one of the following
primary antibodies: rabbit anti-GLT-1a (1:5000; gift from Dr.
Jeffery Rothstein), rabbit anti-GLT-1b (1:5000; gift from Dr.
Paul Rosenberg), rabbit anti-xCT antibody (1:1000; Abcam),
and rabbit anti-EAAT1 (GLAST) antibody (1:5000; Abcam).
Mouse anti β-tubulin was used as loading control (1:5000;
Cell signaling technology). On the next day, membranes were
washed with TBST for five times and then blocked with 3%
milk in TBST for 30min. Membranes were then incubated with
secondary antibodies (anti-rabbit 1:5000, Thermo scientific and
anti-mouse 1:5000, Cell signaling technology) for 90min at room
temperature. Membranes were incubated with the SuperSignal
West Pico Chemiluminescent substrate and further exposed to
Kodak BioMax MR Film (Fisher Inc.); and films were developed
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on SRX-101A machine. MCID system was used for Western
blot analysis, and the results were presented as a percentage of
the ratio of tested protein/β-tubulin, a control loading protein.
The data from ethanol naïve groups were reported as 100%
to evaluate the changes in protein expression in brain regions
following chronic ethanol consumption. In addition, the data
from ethanol vehicle group were reported as 100% to evaluate
the changes in protein expression in brain regions as compared
to β-lactam-treated groups.
Statistical Analyses
Two-way Mixed ANOVA followed by Bonferroni multiple
comparisons was conducted to determine the main effect of Day
or Treatment or Day x Treatment interaction on the average
daily ethanol and water intakes. One-way ANOVA followed by
Dunnett’s post-hoc test was used to determine the effects of
amoxicillin and Augmentin treatments on ethanol and water
intakes in each day. An independent t-test was used to analyze
Western blot data between ethanol naïve and ethanol-vehicle
groups. In addition, one-way ANOVA followed by Newman-
Keuls post-hoc test was used to compare Western blot data
from treatment groups (amoxicillin and Augmentin) and control
group (ethanol-vehicle). Western blot densities from control
groups (ethanol naïve or ethanol vehicle) were converted to
100%. All statistical analyses were based on a p < 0.05 level of
significance.
RESULTS
Effects of Amoxicillin and Augmentin
Treatments on Ethanol and Water Intake
Two-way (mixed) ANOVA followed by Bonferroni multiple
comparisons demonstrated a significant main effect of Day
[F(1, 5) = 31.92, p < 0.0001] and a significant Day x Treatment
interaction [F(2, 10) = 4.559, p < 0.0001] of ethanol intake.
Moreover, one-way ANOVA followed by Dunnett’s post-hoc test
revealed a significant decrease in ethanol intake in amoxicillin-
and Augmentin-treated groups as compared to saline-treated
group fromDay 1 throughDay 5 (p < 0.001), except onDay 5 for
amoxicillin group p < 0.05 (Figure 1A). In addition, statistical
analysis revealed a significant main effect of Day [F(1, 5) = 15.88,
p < 0.0001] and a significant Day x Treatment interaction
[F(2, 10) = 5.285, p < 0.0001] of water consumption. One-
way ANOVA followed by Dunnett’s post-hoc test demonstrated
a significant increase in water consumption in amoxicillin- and
Augmentin-treated groups as compared to saline-treated group
from Day 1 through Day 5 (p < 0.001) except on Day 1 for
amoxicillin group p < 0.01 (Figure 1B).
Effects of Chronic Ethanol Consumption on
GLT-1 Isoforms (GLT-1a and GLT-1b), xCT,
and GLAST Expression in NAc and PFC
UsingWestern blot, we investigated the effects of chronic ethanol
consumption on GLT-1a and GLT-1b expression in NAc and
PFC. Statistical analysis using independent t-test demonstrated
a significant downregulation of GLT-1a (Figure 2A, p < 0.05)
and GLT-1b (Figure 2C, p < 0.01) expression in ethanol vehicle
group as compared to ethanol naïve group in NAc, However,
statistical analysis using independent t-test did not reveal
any changes in GLT-1a (Figure 2B) and GLT-1b (Figure 2D)
expression in PFC.
The effects of chronic ethanol consumption on xCT
and GLAST expression in NAc and PFC were further
investigated between ethanol vehicle and ethanol naïve groups.
Statistical analysis using independent t-test showed a significant
downregulation of xCT expression in ethanol vehicle group as
compared to ethanol naïve group in NAc (Figure 3A; p <
0.05) and PFC (Figure 3B; p < 0.05). However, statistical
analysis did not reveal any significant difference in GLAST
expression between ethanol vehicle and ethanol naïve groups in
NAc (Figure 3C) and PFC (Figure 3D).
Effects of Amoxicillin and Augmentin on
GLT-1 Isoforms (GLT-1a and GLT-1b), xCT,
and GLAST Expression in NAc and PFC
Statistical analysis of GLT-1a and GLT-1b immunoblots in NAc
using one-way ANOVA followed by Newman-Keuls multiple-
comparison post-hoc test revealed a significant upregulation of
GLT-1a [F(2, 12) = 5.061, p = 0.0255, Figure 4A] and GLT-1b
[F(2, 12) = 5.281, p = 0.0226, Figure 5A] in both amoxicillin
and Augmentin groups as compared to ethanol vehicle group. In
addition, statistical analysis of GLT-1a and GLT-1b immunoblots
in PFC revealed a significant upregulation of GLT-1a [F(2,12)=
5.957, p = 0.0160, Figure 4B] and GLT-1b [F(2,12)= 5.320, p =
0.0222, Figure 5B] in Augmentin group only as compared to
ethanol vehicle group.
One-way ANOVA followed by Newman-Keuls multiple-
comparison post-hoc test revealed a significant upregulation of
xCT expression in both amoxicillin and Augmentin treatment
groups as compared to ethanol vehicle group in NAc (Figure 6A)
[F(2, 12) = 6.821, p = 0.0105]. Furthermore, statistical analysis
of xCT expression in PFC did not reveal any significant increase
with amoxicillin-treated group as compared to ethanol vehicle
group. However, Augmentin treatment revealed a significant
upregulation of xCT expression in PFC as compared to ethanol
vehicle and amoxicillin groups (Figure 6B) [F(2, 12) = 4.287, p =
0.0394]. In addition, statistical analysis of GLAST immunoblots
didn’t reveal any significant difference between ethanol vehicle
and treatment groups neither in NAc [F(2, 15) = 0.4441, p =
0.6534] (Figure 7A) nor in PFC [F(2, 15) = 0.5970, p = 0.5732]
(Figure 7B).
DISCUSSION
This study revealed several findings as follows; (a) chronic
ethanol consumption significantly reduced the expression of
GLT-1 isoforms in NAc but not in PFC in male P rats, as
well as reduced xCT expression in both NAc and PFC; (b)
chronic ethanol exposure did not induce any changes in GLAST
expression between ethanol naïve and ethanol vehicle groups;
(c) administration of amoxicillin and Augmentin significantly
reduced ethanol consumption and increased water intake from
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FIGURE 1 | (A) Effects of amoxicillin (AMOX) and Augmentin (AUG) treatments on average daily ethanol intake (g/kg/day) as compared to ethanol vehicle. (B) Effects
of amoxicillin and Augmentin treatments on water consumption (g/kg/day) as compared to ethanol vehicle. Data are represented as mean ± SEM; (*p < 0.05;
**p < 0.01; #p < 0.001), (n = 6 for each group).
Day 1 through Day 5 of the treatment period as compared to
ethanol vehicle group; (d) amoxicillin and Augmentin treatments
increased GLT-1 isoforms and xCT expression in NAc as
compared to ethanol vehicle group; (e) Augmentin, but not
amoxicillin, increased GLT-1 isoforms and xCT expression in
PFC as compared to ethanol vehicle group; and (f) amoxicillin
and Augmentin treatments did not exhibit any changes in
GLAST expression between ethanol vehicle and treatment
groups.
Studies demonstrated that ethanol exposure can lead to
increase extracellular glutamate concentration in NAc in mouse
models (Kapasova and Szumlinski, 2008; Griffin Iii et al.,
2014). Similarly, studies from ours and others demonstrated
that ethanol exposure can also lead to increase in extracellular
glutamate concentration in mesolimbic system, including NAc
in rat models (Moghaddam and Bolinao, 1994; Melendez et al.,
2005; Ding et al., 2013; Das et al., 2015). We suggested
that increase in extracellular glutamate concentration might
be associated in part with reduction in GLT-1 expression in
NAc (Das et al., 2015). In the present study, we reported
for the first time that chronic ethanol consumption decreased
GLT-1a and GLT-1b expression in NAc. We also demonstrated
that ethanol exposure decreased xCT expression in NAc and
PFC. Downregulation of these isoforms alter neuronal and
astrocytic glutamate homeostasis, which may have a critical
role in ethanol intake. Astrocytes are responsible for removing
the majority of extracellular glutamate concentration (Holmseth
et al., 2012; Petr et al., 2015). Glutamate uptake is regulated
mainly by glial GLT-1, which transports extracellular glutamate
into astrocytes and then converts it to glutamine (Reviewed
by ref. Danbolt, 2001). Glutamine might be then released
to extrasynaptic cleft and further converted to glutamate by
neurons. This glutamine-glutamate cycle is themajor mechanism
to recycle glutamate. Further studies are warranted to determine
the role of neuronal and astrocytic glutamate uptake in ethanol
craving.
It is important to note that i.p. injections of ethanol for
seven days increased extracellular glutamate concentration in
NAc, this effect was not associated with the reduction in GLT-1
or GLAST expression (Melendez et al., 2005). However, there
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FIGURE 2 | Effect of chronic ethanol consumption on GLT-1 isoforms (GLT-1a and GLT-1b) expression in NAc and PFC. (A) Statistical analysis showed
significant downregulation of GLT-1a expression in ethanol vehicle group as compared to ethanol naïve (water) group in NAc. (B) Statistical analysis showed no
significant difference of GLT-1a expression in PFC between ethanol naïve and ethanol vehicle groups. (C) Statistical analysis revealed significant downregulation of
GLT-1b expression in ethanol vehicle group as compared to ethanol naïve group in NAc. (D) Statistical analysis also revealed no significant difference of GLT-1b
expression in PFC between ethanol naïve and ethanol vehicle groups. Data are shown as mean ± SEM; (*p < 0.05, **p < 0.01); (n = 5 for each group).
is a possibility that ethanol exposure used in this latter study
may have induced dysfunction of GLT-1, which might lead to
alteration in glutamate transmission. The differential effects on
GLT-1 expression between this latter study and ours might be due
to the use of different ethanol drinking paradigms and animal
models tested for determination of any changes in extracellular
glutamate concentration and GLT-1 expression. Importantly,
upregulation of GLT-1 expression with ceftriaxone attenuated
ethanol intake and cocaine-seeking behavior was associated, in
part, with restoration of extracellular glutamate concentration in
NAc in rats (Sari et al., 2009; Knackstedt et al., 2010; Das et al.,
2015).
Recent studies from our laboratory showed that ceftriaxone
treatment increased the expression of GLT-1 isoforms and
xCT in NAc and PFC and attenuated ethanol intake in
male P rats (Alhaddad et al., 2014a; Rao et al., 2015). In
addition, treatment with other β-lactam antibiotics (cefazolin,
cefoperazone, and ampicillin) reduced ethanol consumption and
induced upregulation of GLT-1 isoforms and xCT expression
in NAc and PFC (Alasmari et al., 2015, 2016). In the present
study, we revealed that chronic ethanol consumption decreased
GLT-1 isoforms and xCT expression in NAc of male P rats.
Importantly, administration of Augmentin reduced ethanol
intake and upregulated GLT-1 isoforms and xCT expression
in NAc and PFC; however, amoxicillin reduced ethanol intake
but upregulated GLT-1 isoforms and xCT expression only
in NAc. The differential effects of Augmentin vs. amoxicillin
on GLT-1 isoforms and xCT might be due to the fact that
Augmentin contains clavulanic acid. Thus, clavulanic acid might
have a synergistic effect with amoxicillin on GLT-1 isoforms
and xCT expression in NAc and PFC. It is important to
note that administration of clavulanic acid upregulated GLT-1
and decreased the reinforcing effect of cocaine in mice (Kim
et al., 2015). Although, amoxicillin treatment upregulated GLT-1
isoforms and xCT in NAc but not in PFC, the drug was found
to reduce ethanol intake in male P rats. There is a possibility
that amoxicillin may increase the activity of GLT-1 isoforms in
PFC. Importantly, we demonstrated that ceftriaxone at lower
dose reduced ethanol intake but did not induce any upregulatory
effects in NAc and PFC (Sari et al., 2011). Previous study showed
that ceftriaxone increased glutamate uptake in hippocampus
without upregulating GLT-1 expression (Lipski et al., 2007).
Furthermore, study from our laboratory demonstrated that
MS-153 [(R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline] reduced
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FIGURE 3 | Effects of chronic ethanol consumption on xCT and GLAST expression in NAc and PFC. (A) Statistical analysis showed significant
downregulation of xCT expression in ethanol vehicle group as compared to ethanol naïve group in NAc. (B) Statistical analysis showed significant downregulation of
xCT expression in ethanol vehicle group as compared to ethanol naïve group in PFC. (C) Statistical analysis revealed no significant difference of GLAST expression in
NAc between ethanol naïve and ethanol vehicle groups. (D) Statistical analysis also revealed no significant difference of GLAST expression in PFC between ethanol
naïve and ethanol vehicle groups. Data are shown as mean ± SEM; (*p < 0.05); (n = 5− 6 for each group).
FIGURE 4 | Effects of Amoxicillin (AMOX) and Augmentin (AUG) on GLT-1a expression in NAc and PFC. (A) Statistical analysis showed significant
upregulation of GLT-1a expression in NAc in both amoxicillin and Augmentin groups compared to ethanol vehicle (saline) group. (B) Statistical analysis revealed
significant upregulation of GLT-1a expression in PFC in Augmentin-treated group compared to ethanol vehicle group. However, no significant difference of GLT-1a
expression was observed between amoxicillin treated group and ethanol vehicle group. Data are shown as mean ± SEM, (*p < 0.05); (n = 5 for each group).
ethanol consumption and upregulated GLT-1 expression in
NAc but not in PFC (Alhaddad et al., 2014b). These data
are in accordance with our present findings with amoxicillin.
The lack of upregulatory effect in GLT-1 isoforms with these
drugs in the PFC might be due to the fact that ethanol did
not downregulate GLT-1 expression in this brain region. It is
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FIGURE 5 | Effects of amoxicillin (AMOX) and Augmentin (AUG) on GLT-1b expression in NAc and PFC. (A) Statistical analysis showed significant
upregulation of GLT-1b expression in NAc in both amoxicillin and Augmentin groups compared to ethanol vehicle (saline) group. (B) Statistical analysis revealed
significant upregulation of GLT-1b expression in PFC in Augmentin-treated group compared to ethanol vehicle group. However, no significant difference of GLT-1b
expression in PFC was observed between amoxicillin-treated group and ethanol vehicle group. Data are shown as mean ± SEM, (*p < 0.05); (n = 5 for each group).
FIGURE 6 | Effects of amoxicillin (AMOX) and Augmentin (AUG) on xCT expression in NAc and PFC. (A) Statistical analysis showed significant upregulation
of xCT expression in NAc in both amoxicillin and Augmentin groups compared to ethanol vehicle (saline) group. (B) Statistical analysis revealed significant upregulation
of xCT expression in PFC in Augmentin-treated group compared to amoxicillin-treated group and ethanol vehicle group. However, no significant difference of xCT
expression was observed between amoxicillin-treated group and ethanol vehicle group. Data are shown as mean ± SEM; (*p < 0.05, **p < 0.01); (n = 5 for each
group).
important to note that amoxicillin as well as other β-lactams may
either increase the function of GLT-1 isoforms or may have other
pharmacological effects that lead to reduction in ethanol intake.
Studies are warranted to determine the effects of amoxicillin
on glutamate uptake and extracellular glutamate concentration
in PFC.
Amoxicillin and Augmentin treatments reduced ethanol
intake and increased water intake as early as Day 1 (24 h after the
first i.p. injection of the drugs). This is in accordance with recent
study that showed similar effect with ceftriaxone (Rao et al.,
2015). This latter study revealed that ceftriaxone upregulated
GLT-1a and GLT-1b in PFC 48 h after the first i.p. injection with
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FIGURE 7 | Effects of amoxicillin (AMOX) and Augmentin (AUG) on GLAST expression in NAc and PFC. (A) Statistical analysis showed no significant
difference of GLAST expression in NAc in both amoxicillin and Augmentin groups compared to ethanol vehicle (saline) group. (B) Statistical analysis also revealed no
significant difference of GLAST expression in PFC in both amoxicillin and Augmentin groups compared to ethanol vehicle group. Data are shown as mean ± SEM;
(n = 5− 6 for each group).
the drug. This study also demonstrated that 5 days treatment
with ceftriaxone increased GLT-1 isoforms and xCT in both
PFC and NAc. The reduction of ethanol intake found as early
as Day 1 with amoxicillin and Augmentin might be due either
to functional increase in GLT-1 isoforms or other unknown
pharmacological effects that are warranted further investigation.
It is important to note that our findings that demonstrated
increase in water intake are in accordance with other studies
using different β-lactam antibiotics (Sari et al., 2011, 2013; Rao
and Sari, 2014; Alasmari et al., 2015, 2016; Rao et al., 2015).
We suggest that this increase in water intake is a compensatory
mechanism by the P rats in order to maintain their fluid intake.
This compensatory mechanism of fluid intake might also be
compared to the increase in water intake that was observed by
the selectively bred high alcohol-consuming rat model during the
short ethanol deprivation intervals (Bell et al., 2008).
Amoxicillin and Augmentin treatments revealed no
significant change in GLAST expression between ethanol
vehicle and treatment groups in NAc and PFC. These results are
in consistent with previous studies from our laboratory showing
that other β-lactam antibiotics did not affect GLAST expression
in NAc and PFC (Alasmari et al., 2015, 2016). GLAST is highly
expressed in the cerebellum to regulate glutamate homeostasis
as compared to forebrain regions such as PFC and NAc, which
highly express GLT-1 (Lehre and Danbolt, 1998; Bauer et al.,
2012; Whitelaw and Robinson, 2013).
In conclusion, we report that amoxicillin and Augmentin
treatments reduced ethanol consumption in male P rats, in part,
through upregulation of GLT-1a, GLT-1b, and xCT expression
in NAc and PFC. The upregulatory effects of Augmentin on
GLT-1a, GLT-1b, and xCT in both NAc and PFC may suggest
that this drug is more effective than amoxicillin. However,
amoxicillin did upregulate GLT-1 isoforms and xCT only in
NAc and yet the drug reduced ethanol intake. We suggest here
that amoxicillin treatment may either lead to an increase in
the activity of these glial glutamate transporters or involves
other pharmacological effects on ethanol intake. This hypothesis
may apply to Augmentin as well. In accordance with our
previous findings, the present study supports the rationale that
both amoxicillin and Augmentin decrease ethanol consumption
putatively via restoration of glutamate homeostasis and other
potential pharmacological effects in the central brain reward
regions. Further studies are warranted to determine potential
pharmacological effects involving these β-lactam antibiotics for
the attenuation of ethanol dependence.
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